Biomarin Pharmaceutical Inc (NASDAQ:BMRN)
| 90.29 Delayed Data As of Jan 14 |  +2.13 / +2.42%Today’s Change | 71.59 Today|||52-Week Range 92.17 | +2.20% Year-to-Date |
Latest BMRN News | Press Releases
No recent news for Biomarin Pharmaceutical Inc.
Today’s Trading
| Previous close | 88.16 |
| Today’s open | 87.62 |
| Day’s range | 86.40 - 90.30 |
| Volume | 55,926 |
| Average volume (3 months) | 1,415,265 |
| Market cap | $16.6B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -107.84% |
| Earnings growth (next 5 years) | +51.10% |
| Revenue growth (last year) | +9.25% |
| P/E ratio | 1,003.2 |
| Price/Sales | 9.12 |
| Price/Book | 3.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TECHBio-Techne Corp | -7.03 | -1.77% |
| EXASExact Sciences Corp | +3.11 | +4.12% |
| ---- | ||
| ---- |
Data as of 4:01pm ET, 01/14/2022
Financials
| Next reporting date | February 24, 2022 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $1.8B |
| Annual profit (last year) | $859.1M |
| Net profit margin | 46.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Rafael, California |
Forecasts
